They showed that among patients treated with non-insulin antidiabetic drugs (with the exception of alpha-glucosidase inhibitors), GLP-1 receptor agonists had the lowest risk ratio for lung cancer (0.49, 95% CI: 0.410.59) compared to insulin regardless of histological type, gender, race, or smoking status
Consequently, Bbs5 / mice treated with semaglutide exhibited rapid weight loss (Figure 5E) and maintained a significant reduction in body weight, exceeding 10% compared with pretreatment levels (Figure 5F)
Healthcare should be engineered for people, and partnerships like this prove it's possible
The GLP-1 market, valued at approximately $30 billion in 2018, is projected to expand dramatically over the next decade, with several of the worlds top-selling drugs now belonging to this class
In Phase 3 trials, about 25% of women on Vyleesi had a meaningful increase in their desire score (measured by a validated Female Sexual Function Index domain) compared to ~17% on placebo, and similarly saw a reduction in sexual distress